Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Duchenne Muscular Dystrophy Market 2018 Forecast to 2023

Publisher Name :
Date: 26-Apr-2018
No. of pages: 104

Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.

Scope of the Report:

This report focuses on the Duchenne Muscular Dystrophy in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- PTC Therapeutics

- Sarepta Therapeutics

- Bristol-Myers Squibb

- ITALFARMACO

- BioMarin

- Daiichi Sankyo

- Solid Biosciences

- Summit Therapeutics

- FibroGen

- NS Pharma

- Pfizer

- ReveraGen BioPharma

- Wave Life

- Genethon

- Santhera Pharmaceuticals

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Deflazacort

- Prednisone

- Others

Market Segment by Applications, can be divided into

- Male

- Female

There are 15 Chapters to deeply display the global Duchenne Muscular Dystrophy market.

Chapter 1, to describe Duchenne Muscular Dystrophy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Duchenne Muscular Dystrophy, with sales, revenue, and price of Duchenne Muscular Dystrophy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Duchenne Muscular Dystrophy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Duchenne Muscular Dystrophy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Duchenne Muscular Dystrophy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Duchenne Muscular Dystrophy Market 2018 Forecast to 2023

Table of Contents

1 Market Overview
1.1 Duchenne Muscular Dystrophy Introduction
1.2 Market Analysis by Type
1.2.1 Deflazacort
1.2.2 Prednisone
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Male
1.3.2 Female
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 PTC Therapeutics
2.1.1 Business Overview
2.1.2 Duchenne Muscular Dystrophy Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sarepta Therapeutics
2.2.1 Business Overview
2.2.2 Duchenne Muscular Dystrophy Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.2 Duchenne Muscular Dystrophy Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 ITALFARMACO
2.4.1 Business Overview
2.4.2 Duchenne Muscular Dystrophy Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 ITALFARMACO Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 BioMarin
2.5.1 Business Overview
2.5.2 Duchenne Muscular Dystrophy Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 BioMarin Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Daiichi Sankyo
2.6.1 Business Overview
2.6.2 Duchenne Muscular Dystrophy Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Daiichi Sankyo Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Solid Biosciences
2.7.1 Business Overview
2.7.2 Duchenne Muscular Dystrophy Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Solid Biosciences Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Summit Therapeutics
2.8.1 Business Overview
2.8.2 Duchenne Muscular Dystrophy Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Summit Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 FibroGen
2.9.1 Business Overview
2.9.2 Duchenne Muscular Dystrophy Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 FibroGen Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 NS Pharma
2.10.1 Business Overview
2.10.2 Duchenne Muscular Dystrophy Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 NS Pharma Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Duchenne Muscular Dystrophy Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Pfizer Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 ReveraGen BioPharma
2.12.1 Business Overview
2.12.2 Duchenne Muscular Dystrophy Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 ReveraGen BioPharma Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Wave Life
2.13.1 Business Overview
2.13.2 Duchenne Muscular Dystrophy Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Wave Life Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Genethon
2.14.1 Business Overview
2.14.2 Duchenne Muscular Dystrophy Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Genethon Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Santhera Pharmaceuticals
2.15.1 Business Overview
2.15.2 Duchenne Muscular Dystrophy Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Duchenne Muscular Dystrophy Market Competition, by Manufacturer
3.1 Global Duchenne Muscular Dystrophy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Duchenne Muscular Dystrophy Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Duchenne Muscular Dystrophy Manufacturer Market Share in 2017
3.4.2 Top 5 Duchenne Muscular Dystrophy Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Duchenne Muscular Dystrophy Market Analysis by Regions
4.1 Global Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Regions
4.1.1 Global Duchenne Muscular Dystrophy Sales by Regions (2013-2018)
4.1.2 Global Duchenne Muscular Dystrophy Revenue by Regions (2013-2018)
4.2 North America Duchenne Muscular Dystrophy Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Duchenne Muscular Dystrophy Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Duchenne Muscular Dystrophy Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Duchenne Muscular Dystrophy Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Duchenne Muscular Dystrophy Sales, Revenue and Growth Rate (2013-2018)
5 North America Duchenne Muscular Dystrophy by Countries, Type, Application and Manufacturers
5.1 North America Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Countries
5.1.1 North America Duchenne Muscular Dystrophy Sales by Countries (2013-2018)
5.1.2 North America Duchenne Muscular Dystrophy Revenue by Countries (2013-2018)
5.1.3 United States Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
5.1.4 Canada Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
5.1.5 Mexico Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
5.2 North America Duchenne Muscular Dystrophy Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Duchenne Muscular Dystrophy Sales by Manufacturers (2016-2017)
5.2.2 North America Duchenne Muscular Dystrophy Revenue by Manufacturers (2016-2017)
5.3 North America Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Duchenne Muscular Dystrophy Sales and Sales Share by Type (2013-2018)
5.3.2 North America Duchenne Muscular Dystrophy Revenue and Revenue Share by Type (2013-2018)
5.4 North America Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Duchenne Muscular Dystrophy Sales and Sales Share by Application (2013-2018)
5.4.2 North America Duchenne Muscular Dystrophy Revenue and Revenue Share by Application (2013-2018)
6 Europe Duchenne Muscular Dystrophy by Countries, Type, Application and Manufacturers
6.1 Europe Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Countries
6.1.1 Europe Duchenne Muscular Dystrophy Sales by Countries (2013-2018)
6.1.2 Europe Duchenne Muscular Dystrophy Revenue by Countries (2013-2018)
6.1.3 Germany Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
6.1.4 UK Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
6.1.5 France Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
6.1.6 Russia Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
6.1.7 Italy Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
6.2 Europe Duchenne Muscular Dystrophy Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Duchenne Muscular Dystrophy Sales by Manufacturers (2016-2017)
6.2.2 Europe Duchenne Muscular Dystrophy Revenue by Manufacturers (2016-2017)
6.3 Europe Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Duchenne Muscular Dystrophy Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Duchenne Muscular Dystrophy Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Duchenne Muscular Dystrophy Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Duchenne Muscular Dystrophy Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Duchenne Muscular Dystrophy by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Duchenne Muscular Dystrophy Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue by Countries (2013-2018)
7.1.3 China Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
7.1.4 Japan Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
7.1.5 Korea Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
7.1.6 India Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Duchenne Muscular Dystrophy Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Duchenne Muscular Dystrophy Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Duchenne Muscular Dystrophy Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Duchenne Muscular Dystrophy Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue and Revenue Share by Application (2013-2018)
8 South America Duchenne Muscular Dystrophy by Countries, Type, Application and Manufacturers
8.1 South America Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Countries
8.1.1 South America Duchenne Muscular Dystrophy Sales by Countries (2013-2018)
8.1.2 South America Duchenne Muscular Dystrophy Revenue by Countries (2013-2018)
8.1.3 Brazil Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
8.1.4 Argentina Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
8.1.5 Colombia Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
8.2 South America Duchenne Muscular Dystrophy Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Duchenne Muscular Dystrophy Sales by Manufacturers (2016-2017)
8.2.2 South America Duchenne Muscular Dystrophy Revenue by Manufacturers (2016-2017)
8.3 South America Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Duchenne Muscular Dystrophy Sales and Sales Share by Type (2013-2018)
8.3.2 South America Duchenne Muscular Dystrophy Revenue and Revenue Share by Type (2013-2018)
8.4 South America Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Duchenne Muscular Dystrophy Sales and Sales Share by Application (2013-2018)
8.4.2 South America Duchenne Muscular Dystrophy Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Duchenne Muscular Dystrophy by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Duchenne Muscular Dystrophy Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Duchenne Muscular Dystrophy Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
9.1.4 UAE Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
9.1.5 Egypt Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
9.1.7 South Africa Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Duchenne Muscular Dystrophy Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Duchenne Muscular Dystrophy Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Duchenne Muscular Dystrophy Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Duchenne Muscular Dystrophy Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Duchenne Muscular Dystrophy Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Duchenne Muscular Dystrophy Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Duchenne Muscular Dystrophy Revenue and Revenue Share by Application (2013-2018)
10 Global Duchenne Muscular Dystrophy Market Segment by Type
10.1 Global Duchenne Muscular Dystrophy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Duchenne Muscular Dystrophy Sales and Market Share by Type (2013-2018)
10.1.2 Global Duchenne Muscular Dystrophy Revenue and Market Share by Type (2013-2018)
10.2 Deflazacort Sales Growth and Price
10.2.1 Global Deflazacort Sales Growth (2013-2018)
10.2.2 Global Deflazacort Price (2013-2018)
10.3 Prednisone Sales Growth and Price
10.3.1 Global Prednisone Sales Growth (2013-2018)
10.3.2 Global Prednisone Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Duchenne Muscular Dystrophy Market Segment by Application
11.1 Global Duchenne Muscular Dystrophy Sales Market Share by Application (2013-2018)
11.2 Male Sales Growth (2013-2018)
11.3 Female Sales Growth (2013-2018)
12 Duchenne Muscular Dystrophy Market Forecast (2018-2023)
12.1 Global Duchenne Muscular Dystrophy Sales, Revenue and Growth Rate (2018-2023)
12.2 Duchenne Muscular Dystrophy Market Forecast by Regions (2018-2023)
12.2.1 North America Duchenne Muscular Dystrophy Market Forecast (2018-2023)
12.2.2 Europe Duchenne Muscular Dystrophy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Duchenne Muscular Dystrophy Market Forecast (2018-2023)
12.2.4 South America Duchenne Muscular Dystrophy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Duchenne Muscular Dystrophy Market Forecast (2018-2023)
12.3 Duchenne Muscular Dystrophy Market Forecast by Type (2018-2023)
12.3.1 Global Duchenne Muscular Dystrophy Sales Forecast by Type (2018-2023)
12.3.2 Global Duchenne Muscular Dystrophy Market Share Forecast by Type (2018-2023)
12.4 Duchenne Muscular Dystrophy Market Forecast by Application (2018-2023)
12.4.1 Global Duchenne Muscular Dystrophy Sales Forecast by Application (2018-2023)
12.4.2 Global Duchenne Muscular Dystrophy Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures
Figure Duchenne Muscular Dystrophy Picture
Table Product Specifications of Duchenne Muscular Dystrophy
Figure Global Duchenne Muscular Dystrophy CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Duchenne Muscular Dystrophy CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Duchenne Muscular Dystrophy by Types in 2017
Figure Deflazacort Picture
Figure Prednisone Picture
Figure Others Picture
Figure Duchenne Muscular Dystrophy Sales Market Share by Applications in 2017
Figure Male Picture
Figure Female Picture
Figure United States Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure France Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure UK Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure China Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure India Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Duchenne Muscular Dystrophy Revenue (Value) and Growth Rate (2013-2023)
Table PTC Therapeutics Basic Information, Manufacturing Base and Competitors
Table PTC Therapeutics Duchenne Muscular Dystrophy Type and Applications
Table PTC Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Type and Applications
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Type and Applications
Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ITALFARMACO Basic Information, Manufacturing Base and Competitors
Table ITALFARMACO Duchenne Muscular Dystrophy Type and Applications
Table ITALFARMACO Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BioMarin Basic Information, Manufacturing Base and Competitors
Table BioMarin Duchenne Muscular Dystrophy Type and Applications
Table BioMarin Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Duchenne Muscular Dystrophy Type and Applications
Table Daiichi Sankyo Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Solid Biosciences Basic Information, Manufacturing Base and Competitors
Table Solid Biosciences Duchenne Muscular Dystrophy Type and Applications
Table Solid Biosciences Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Summit Therapeutics Basic Information, Manufacturing Base and Competitors
Table Summit Therapeutics Duchenne Muscular Dystrophy Type and Applications
Table Summit Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table FibroGen Basic Information, Manufacturing Base and Competitors
Table FibroGen Duchenne Muscular Dystrophy Type and Applications
Table FibroGen Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table NS Pharma Basic Information, Manufacturing Base and Competitors
Table NS Pharma Duchenne Muscular Dystrophy Type and Applications
Table NS Pharma Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Duchenne Muscular Dystrophy Type and Applications
Table Pfizer Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ReveraGen BioPharma Basic Information, Manufacturing Base and Competitors
Table ReveraGen BioPharma Duchenne Muscular Dystrophy Type and Applications
Table ReveraGen BioPharma Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wave Life Basic Information, Manufacturing Base and Competitors
Table Wave Life Duchenne Muscular Dystrophy Type and Applications
Table Wave Life Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Genethon Basic Information, Manufacturing Base and Competitors
Table Genethon Duchenne Muscular Dystrophy Type and Applications
Table Genethon Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Santhera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Santhera Pharmaceuticals Duchenne Muscular Dystrophy Type and Applications
Table Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017)
Figure Global Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016
Figure Global Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017
Table Global Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016
Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017
Table Global Duchenne Muscular Dystrophy Price by Manufacturer (2016-2017)
Figure Top 3 Duchenne Muscular Dystrophy Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Duchenne Muscular Dystrophy Manufacturer (Revenue) Market Share in 2017
Figure Global Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Global Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Table Global Duchenne Muscular Dystrophy Sales by Regions (2013-2018)
Table Global Duchenne Muscular Dystrophy Sales Market Share by Regions (2013-2018)
Table Global Duchenne Muscular Dystrophy Revenue by Regions (2013-2018)
Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Regions in 2013
Figure Global Duchenne Muscular Dystrophy Revenue Market Share by Regions in 2017
Figure North America Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure North America Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Figure Europe Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Europe Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Figure South America Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure South America Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Figure North America Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Table North America Duchenne Muscular Dystrophy Sales by Countries (2013-2018)
Table North America Duchenne Muscular Dystrophy Sales Market Share by Countries (2013-2018)
Figure North America Duchenne Muscular Dystrophy Sales Market Share by Countries in 2013
Figure North America Duchenne Muscular Dystrophy Sales Market Share by Countries in 2017
Table North America Duchenne Muscular Dystrophy Revenue by Countries (2013-2018)
Table North America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2013-2018)
Figure North America Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2013
Figure North America Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2017
Figure United States Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Canada Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Mexico Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Table North America Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017)
Figure North America Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016
Figure North America Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017
Table North America Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017)
Figure North America Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016
Figure North America Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017
Table North America Duchenne Muscular Dystrophy Sales by Type (2013-2018)
Table North America Duchenne Muscular Dystrophy Sales Share by Type (2013-2018)
Table North America Duchenne Muscular Dystrophy Revenue by Type (2013-2018)
Table North America Duchenne Muscular Dystrophy Revenue Share by Type (2013-2018)
Table North America Duchenne Muscular Dystrophy Sales by Application (2013-2018)
Table North America Duchenne Muscular Dystrophy Sales Share by Application (2013-2018)
Table North America Duchenne Muscular Dystrophy Revenue by Application (2013-2018)
Table North America Duchenne Muscular Dystrophy Revenue Share by Application (2013-2018)
Figure Europe Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Table Europe Duchenne Muscular Dystrophy Sales by Countries (2013-2018)
Table Europe Duchenne Muscular Dystrophy Sales Market Share by Countries (2013-2018)
Table Europe Duchenne Muscular Dystrophy Revenue by Countries (2013-2018)
Figure Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2016
Figure Europe Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2017
Figure Germany Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure UK Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure France Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Russia Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Italy Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Table Europe Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017)
Figure Europe Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016
Figure Europe Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017
Table Europe Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017)
Figure Europe Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016
Figure Europe Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017
Table Europe Duchenne Muscular Dystrophy Sales by Type (2013-2018)
Table Europe Duchenne Muscular Dystrophy Sales Share by Type (2013-2018)
Table Europe Duchenne Muscular Dystrophy Revenue by Type (2013-2018)
Table Europe Duchenne Muscular Dystrophy Revenue Share by Type (2013-2018)
Table Europe Duchenne Muscular Dystrophy Sales by Application (2013-2018)
Table Europe Duchenne Muscular Dystrophy Sales Share by Application (2013-2018)
Table Europe Duchenne Muscular Dystrophy Revenue by Application (2013-2018)
Table Europe Duchenne Muscular Dystrophy Revenue Share by Application (2013-2018)
Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Sales by Countries (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Countries 2017
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Countries (2013-2018)
Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Countries 2017
Figure China Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Japan Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Korea Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure India Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Southeast Asia Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Duchenne Muscular Dystrophy Sales by Type (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Sales Share by Type (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Type (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue Share by Type (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Sales by Application (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Sales Share by Application (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue by Application (2013-2018)
Table Asia-Pacific Duchenne Muscular Dystrophy Revenue Share by Application (2013-2018)
Figure South America Duchenne Muscular Dystrophy Revenue and Growth Rate (2013-2018)
Table South America Duchenne Muscular Dystrophy Sales by Countries (2013-2018)
Table South America Duchenne Muscular Dystrophy Sales Market Share by Countries (2013-2018)
Figure South America Duchenne Muscular Dystrophy Sales Market Share by Countries in 2017
Table South America Duchenne Muscular Dystrophy Revenue by Countries (2013-2018)
Table South America Duchenne Muscular Dystrophy Revenue Market Share by Countries (2013-2018)
Figure South America Duchenne Muscular Dystrophy Revenue Market Share by Countries in 2017
Figure Brazil Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Argentina Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Figure Colombia Duchenne Muscular Dystrophy Sales and Growth Rate (2013-2018)
Table South America Duchenne Muscular Dystrophy Sales by Manufacturer (2016-2017)
Figure South America Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2016
Figure South America Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2017
Table South America Duchenne Muscular Dystrophy Revenue by Manufacturer (2016-2017)
Figure South America Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2016
Figure South America Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2017
Table South America Duchenne Muscular Dystrophy Sales by Type (2013-2018)
Tabl
  • Global Veterinary Healthcare Product Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 108
    This report studies the global market size of Veterinary Healthcare Product in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Veterinary Healthcare Product in these regions. This research report categorizes the global Veterinary Healthcare Product market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, f......
  • Global Amiodarone Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 112
    Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. In 2017, the global Amiodarone market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and pro......
  • Global Sotalol Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 112
    Sotalol is a medication used to treat abnormal heart rhythms. Sotalol is a non-selective competitive beta-adrenergic receptor blocker that also exhibits Class III antiarrhythmic properties. In 2017, the global Sotalol market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Sotalol market based on company, product type, application and key regions. ......
  • Global Bisoprolol Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 111
    Bisoprolol is a medication most commonly used for heart diseases. This specifically includes high blood pressure, chest pain from not enough blood flow to the heart, and heart failure. It is taken by mouth. In 2017, the global Bisoprolol market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Bisoprolol market based on company, product type, application and......
  • Global Fiber Supplements Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Fiber Supplements in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements in these regions. This research report categorizes the global Fiber Supplements market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opport......
  • Global PVA Embolization Particles Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 110
    Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells. In 2017, the global PVA Embolization Particles market size was xx million US$ and is forecast to xx million US in 202......
  • Global Fiber Supplements Powder Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 93
    This report studies the global market size of Fiber Supplements Powder in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements Powder in these regions. This research report categorizes the global Fiber Supplements Powder market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, m......
  • Global Fiber Supplements Capsule Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 91
    This report studies the global market size of Fiber Supplements Capsule in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements Capsule in these regions. This research report categorizes the global Fiber Supplements Capsule market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends......
  • Global Fiber Supplements Chewable Tablets Market Insights, Forecast to 2025
    Published: 16-Nov-2018        Price: US 3900 Onwards        Pages: 94
    This report studies the global market size of Fiber Supplements Chewable Tablets in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Fiber Supplements Chewable Tablets in these regions. This research report categorizes the global Fiber Supplements Chewable Tablets market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs